OPI 409 (Chlordiazepoxide and Clidinium 5 mg / 2.5 mg)
Pill imprint OPI 409 has been identified as Chlordiazepoxide hydrochloride and clidinium bromide 5 mg / 2.5 mg.
Chlordiazepoxide/clidinium is used in the treatment of irritable bowel syndrome; peptic ulcer; enterocolitis and belongs to the drug class anticholinergics/antispasmodics. There is positive evidence of human fetal risk during pregnancy. Chlordiazepoxide/clidinium 5 mg / 2.5 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
- 5 mg / 2.5 mg
- Prescription only
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Green No. 3
More about chlordiazepoxide/clidinium
- Chlordiazepoxide and clidinium
- Chlordiazepoxide and clidinium (Advanced Reading)
- Other brands: Librax
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.